Viridian Therapeutics, Inc. (VRDN)
31.02
-0.52
(-1.65%)
USD |
NASDAQ |
Dec 30, 16:00
31.02
0.00 (0.00%)
After-Hours: 20:00
Viridian Therapeutics Market Cap: 2.961B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Orthofix Medical, Inc. | 607.06M |
| ADMA Biologics, Inc. | 4.370B |
| Avantor, Inc. | 7.820B |
| Immunovant, Inc. | 4.443B |
| Perspective Therapeutics, Inc. | 203.69M |
Market Cap Related Metrics
| PS Ratio | 35.58 |
| Price to Book Value | 9.426 |
| Price | 31.02 |
| Earnings Yield | -11.39% |